JP2002338480A - Method for producing antispirillar agent pill - Google Patents
Method for producing antispirillar agent pillInfo
- Publication number
- JP2002338480A JP2002338480A JP2001147654A JP2001147654A JP2002338480A JP 2002338480 A JP2002338480 A JP 2002338480A JP 2001147654 A JP2001147654 A JP 2001147654A JP 2001147654 A JP2001147654 A JP 2001147654A JP 2002338480 A JP2002338480 A JP 2002338480A
- Authority
- JP
- Japan
- Prior art keywords
- pill
- producing
- pills
- antispirillar
- pork
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
Description
【０００１】[0001]
【発明の属する技術分野】本発明は抗螺旋菌剤丸薬の製
法に関するものであり、とくに石膏と塩化第一水銀を粉
末状にしたものを豚肉と混合し、丸薬状に整え、ゴマ油
で揚げたものである。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for producing an anti-spirobacterial pill, in particular, a mixture of gypsum and mercurous chloride in powder form, mixed with pork, prepared into pill form, and fried in sesame oil. Things.
【０００２】[0002]
【従来の技術】梅毒は世界各地にみられ、根治が困難な
性病の一つである。特定の発症年齢がなく、子供から大
人まで感染する可能性がある。梅毒の原因は螺旋菌（ス
ピロヘータ）で、梅毒の感染初期において接触した皮膚
組織には無痛の潰瘍がみられる。表面が糜爛し、押すと
透明な滲出液が出てくる。滲出液には大量の螺旋菌が含
まれ、感染性が極めて高い。且つ患者の体は熱りやす
く、末期には皮膚、上表皮組織、骨格筋肉組織まで侵さ
れる。西洋の薬や注射は症状を抑制することはできる
が、根治することができず、同時に薬に対する耐性が発
生しやすい。2. Description of the Related Art Syphilis is found in various parts of the world and is one of the venereal diseases that are difficult to cure. It has no specific age of onset and can be transmitted from children to adults. The cause of syphilis is Spirochete, a painless ulcer found in the skin tissue contacted during the early stages of syphilis infection. The surface is eroded and a clear exudate comes out when pressed. The exudate contains a large amount of helical bacteria and is highly infectious. In addition, the patient's body is easily heated, and in the late stage, the skin, epidermal tissue, and skeletal muscle tissue are affected. Western drugs and injections can suppress the symptoms, but cannot cure them, and at the same time are more likely to develop resistance to the drugs.
【０００３】[0003]
【発明が解決しようとする課題】このため、本発明では
梅毒を根治できる抗螺旋菌剤丸薬の製法を提供すること
を目的とする。SUMMARY OF THE INVENTION Accordingly, an object of the present invention is to provide a method for producing an anti-spirobacterial pill which can cure syphilis.
【０００４】[0004]
【課題を解決するための手段】本発明者が薬草に対する
研究を長年続けてきた結果、ついに本発明を完成した。
本発明の抗螺旋菌剤丸薬の製法では、先ず石膏と塩化第
一水銀（Hg2Cl2）を研磨して粉末状とし、さらに豚肉に
入れて攪拌したあと、手で小さい顆粒状の丸薬に形を整
え、ゴマ油で揚げる。冷却１時間後に冷凍し、丸薬とす
る。前記の数種類の成分の混合物はさらに精錬すること
もできる。服用して、体内の螺旋菌を死滅させた後、便
や尿の排泄物とともに体外に排出する。これにより、螺
旋菌の根絶を達成でき、高い医療効果を得ることができ
る。Means for Solving the Problems As a result of many years of research on herbs, the present inventors have finally completed the present invention.
In the manufacturing method of the anti-spirobacterial pill of the present invention, first, gypsum and mercuric chloride (Hg 2 Cl 2 ) are polished to a powdery form, then put in pork and stirred, and then manually made into small granular pills. Shape and fry in sesame oil. One hour after cooling, freeze to make a pill. Mixtures of the several components mentioned can be further refined. After taking to kill helical bacteria in the body, it is excreted along with stool and urine excrement. As a result, eradication of the spiral bacterium can be achieved, and a high medical effect can be obtained.
【０００５】[0005]
【発明の実施の形態】本発明の特徴や効果をより明確に
理解できるよう、以下に詳細な説明を示す。BEST MODE FOR CARRYING OUT THE INVENTION A detailed description will be given below so that the features and effects of the present invention can be understood more clearly.
【０００６】図１に本発明の製造フローチャートを示
す。先ず、石膏２と塩化第一水銀（Hg 2Cl2）１を研磨し
て粉末状３とし、生の豚肉４と混練した後、手で小顆粒
の丸薬状に整え、さらにゴマ油５で揚げる。油の温度は
１５０℃、時間は３分間。常温冷却して１時間後に冷凍
処理７し、マイナス３０℃で２４時間冷凍して、丸薬８
とする。丸薬１個の重さは０．１gで、そのうち豚肉が
０．０９g（90％）、塩化第一水銀が０．００３５ｇ
（3.5％）、石膏が０．００１５ｇ（1.5％）、ゴマ油が
０．００５ｇ（5%）を占めている。前記の数種類の成分
の混合物はさらに精錬することもできる。服用により体
内で螺旋菌が死滅し、便や尿などの排泄物とともに体外
に排出され、連続服用２年半後には螺旋菌を完全に排除
することができる。FIG. 1 shows a manufacturing flowchart of the present invention.
You. First, gypsum 2 and mercuric chloride (Hg TwoClTwo) Polish 1
Powder 3 and kneaded with raw pork 4
And then fry in sesame oil 5. Oil temperature is
150 ° C, time is 3 minutes. Cool at room temperature and freeze for 1 hour
Treat 7 and freeze at -30 ° C for 24 hours.
And Each pill weighs 0.1 g, of which pork is
0.09g (90%), 0.0035g mercurous chloride
(3.5%), gypsum 0.0015g (1.5%), sesame oil
It accounts for 0.005 g (5%). Some of the above ingredients
Can be further refined. Body by taking
Spiral bacteria are killed inside the body and excreted with feces and urine
, And after two and a half years of continuous dosing, completely eliminate helical bacteria
can do.
【０００７】塩化第一水銀１は体内において抗菌性を持
つ可溶性水銀塩となり、螺旋菌を死滅させると一方で、
腸壁を刺激し、胃腸の蠕動を増加し、さらには腸液の分
泌を促進して、下痢が生じることがある。服用の初期
（最初の半年）は下痢が発生するが、その後徐々に下痢
は緩和される。[0007] Mercurous chloride 1 becomes a soluble mercury salt having antibacterial properties in the body, and kills helical bacteria.
It may irritate the intestinal wall, increase gastrointestinal peristalsis, and even promote intestinal secretion, resulting in diarrhea. Diarrhea occurs early in the first dose (first half a year), but gradually diminishes thereafter.
【０００８】また、豚肉４に含まれる油脂が胃を保護
し、塩化第一水銀１が過度に胃壁を刺激することを防止
する。さらに石膏２は患者の体の熱りを冷ます効果を持
つ。The fats and oils contained in the pork 4 protect the stomach and prevent the mercurous chloride 1 from excessively irritating the stomach wall. Further, the gypsum 2 has an effect of cooling the heat of the patient's body.
【０００９】さらに、ゴマ油５にはセサミ・フェノール
が大量に含まれる。セサミ・フェノールは塩化第一水銀
の抗菌力を高める作用を持ち（図２を参照）、有効に螺
旋菌を死滅させ、螺旋菌の死体を便や尿とともに体外に
排出できる。この処方によって、螺旋菌を根絶し、高い
医療効果を得ることができる。Furthermore, sesame oil 5 contains a large amount of sesame phenol. Sesame phenol has the effect of increasing the antibacterial activity of mercurous chloride (see Fig. 2), effectively kills helical bacteria, and can excrete the corpses of helical bacteria out of the body with stool and urine. This formulation can eradicate helical bacteria and achieve a high medical effect.
【００１０】[0010]
【発明の効果】本発明は高い実用性を備え、以下の長所
を有する。 １．螺旋菌を完全に死滅させることができる。 ２．経口で服用でき、手術や注射が必要ない。 ３．可溶性水銀塩が便や尿から排出され、体内に残留せ
ず蓄積されない。 ４．服用初期に下痢を伴う以外に、その他の副作用がな
い。 ５．商業的な利用価値が高い。The present invention has high practicality and has the following advantages. 1. Spiral bacteria can be completely killed. 2. It can be taken orally and does not require surgery or injections. 3. Soluble mercury salts are excreted from stool and urine and do not remain and accumulate in the body. 4. There are no other side effects other than with diarrhea in the first dose. 5. High commercial value.
【図１】本発明の丸薬製造フローチャートFIG. 1 is a pill manufacturing flowchart of the present invention.
【図２】本発明の効果増加剤の影響FIG. 2 shows the effect of the effect enhancer of the present invention.
【図３】本考案の螺旋菌生存量と時間の関連Fig. 3 Relationship between survival time of helical bacteria and time of the present invention
(1)塩化第一水銀 (2)石膏 (3)研磨 (4)豚肉（生） (5)ゴマ油 (6)常温冷却 (7)冷凍 (8)丸薬 (1) Mercurous chloride (2) Gypsum (3) Polishing (4) Pork (raw) (5) Sesame oil (6) Room temperature cooling (7) Frozen (8) Pills
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 ＦＩ テーマコート゛(参考） Ａ６１Ｐ 15/00 Ａ６１Ｐ 15/00 ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 7 Identification symbol FI Theme coat ゛ (Reference) A61P 15/00 A61P 15/00
Claims (2)
し、生の豚肉と混練した後、手で小顆粒の丸薬状に整
え、さらにゴマ油５で揚げ、前記ゴマ油の温度を１５０
℃、揚げる時間を３分間とし、常温冷却して１時間後に
マイナス３０℃で２４時間冷凍して、丸薬とすることを
特徴とする抗螺旋菌剤丸薬の製法。1. Gypsum and mercurous chloride are ground to a powder form, kneaded with raw pork, prepared by hand into small granule pills, fried in sesame oil 5, and heated to a temperature of 150 g.
A method for preparing an anti-spirobacterial pill, characterized in that the pill is fried for 3 minutes at room temperature, cooled to normal temperature, and then frozen for 1 hour at -30 ° C for 24 hours.
肉が０．０９g（90％）、塩化第一水銀が０．００３５
ｇ（3.5％）、石膏が０．００１５ｇ（1.5％）、ゴマ油
が０．００５ｇ（5%）を占めることを特徴とする、請求
項１に記載の抗螺旋菌剤丸薬の製法。2. Each pill weighs 0.1 g, of which 0.09 g (90%) of pork and 0.0035 of mercurous chloride.
2. The method of claim 1, wherein g (3.5%), gypsum accounts for 0.0015 g (1.5%), and sesame oil accounts for 0.005 g (5%).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001147654A JP2002338480A (en) | 2001-05-17 | 2001-05-17 | Method for producing antispirillar agent pill |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001147654A JP2002338480A (en) | 2001-05-17 | 2001-05-17 | Method for producing antispirillar agent pill |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002338480A true JP2002338480A (en) | 2002-11-27 |
| JP2002338480A5 JP2002338480A5 (en) | 2005-04-07 |
Family
ID=18993104
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001147654A Pending JP2002338480A (en) | 2001-05-17 | 2001-05-17 | Method for producing antispirillar agent pill |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2002338480A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08511528A (en) * | 1993-06-11 | 1996-12-03 | ザ、プロクター、エンド、ギャンブル、カンパニー | Methods and compositions for assisting periodontal tissue regeneration |
| JPH1160416A (en) * | 1997-08-14 | 1999-03-02 | Kubota Corp | Amorphous antimicrobial titanate compound and its production |
| JP2003503333A (en) * | 1999-06-25 | 2003-01-28 | ザ、プロクター、エンド、ギャンブル、カンパニー | Antimicrobial composition for topical use |
-
2001
- 2001-05-17 JP JP2001147654A patent/JP2002338480A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08511528A (en) * | 1993-06-11 | 1996-12-03 | ザ、プロクター、エンド、ギャンブル、カンパニー | Methods and compositions for assisting periodontal tissue regeneration |
| JPH1160416A (en) * | 1997-08-14 | 1999-03-02 | Kubota Corp | Amorphous antimicrobial titanate compound and its production |
| JP2003503333A (en) * | 1999-06-25 | 2003-01-28 | ザ、プロクター、エンド、ギャンブル、カンパニー | Antimicrobial composition for topical use |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101961404A (en) | Chinese medicinal paste for treating dermatosis and preparation method thereof | |
| CN104042685A (en) | Externally-applied powder drug for treating scabies and preparing method thereof | |
| JP2002338480A (en) | Method for producing antispirillar agent pill | |
| KR100864161B1 (en) | Composition for treating hemorrhoids and manufacturing method for the same | |
| CN108210548A (en) | Chinese medicine ointment for traumatic surface and preparation method thereof | |
| CN1231231C (en) | Ointment for treating burns and scalds and its prepn. | |
| US20110038954A1 (en) | Calcium-rich alkaline power produced from processed mollusc shells | |
| JP2021506980A (en) | Therapeutic compositions and treatments for Ehlers-Danlos syndrome | |
| Barber | Benign lymphogranuloma of Schaumann with apparent involvement of the anterior pituitary | |
| Weiss | A Method of Treatment of Mercuric Chlorid Poisoning | |
| JP2001302531A (en) | Use of garlic extract as prophylactic and therapeutic agent for prostatic cancer and bladder cancer | |
| CN100342869C (en) | Externally used traditional Chinese medicine liquor for trauma and preparation method thereof | |
| CN108261463A (en) | A kind of windproof Chinese medicine of folium artemisiae argyi controls cutaneous pruritus effervescent tablet | |
| Shreeve | The alternative dictionary of symptoms and cures | |
| MUSPRATT | A Mirror | |
| RU2080843C1 (en) | Method for treating cases of constipation | |
| Abehsera | The Healing Power Of Clay: The Natural Remedy for Dozens of Common Ailments | |
| CN114081173A (en) | Food therapy formula for discharging gout stones in diseased joints | |
| CN108836981A (en) | A kind of putrefaction-removing granulation-promoting paste and preparation method thereof | |
| CN1382452A (en) | Process for preparing medicinal pill able to kill spiroplasmavirus | |
| Ellis | A Practical Manual of the Diseases of Children with a Formulary | |
| DURnANT | MEDICAL CASES. | |
| POTASH | Discharged well. | |
| WO2020024265A1 (en) | Traditional chinese medicine preparation, preparation method therefor and application thereof | |
| Cameron | ILLUSTRATIONS OF ANTISEPTIC SURGERY. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040524 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040524 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080212 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20090303 |